Jun 2026 (Q2 FY26) — Jul 23, 2026
Acme United Q2 FY26 — Strong Sales Growth Driven by MyMedic Acquisition and Core Business Recovery
Read the full callAcme United earnings: last reported Thu, 23 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 62.7 | +16.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 10.9 | −0.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 5.1 | +6.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $38.48 on 22 Oct 2025 → $63.48. High $64.17 (22 Oct 2026), low $35.5 (20 Nov 2025).
Overview
Call summaries
Acme United Q2 FY26 — Strong Sales Growth Driven by MyMedic Acquisition and Core Business Recovery
Read the full callEvery analysed call
Financials
Net profit, year on year: +6% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 48 | 46 | 46 | 54 | 49 | 48 | 52 | 63 |
| Operating profit | 3 | 2 | 2 | 6 | 3 | 3 | 2 | 7 |
| Operating margin | 6.1% | 5.0% | 5.3% | 11.8% | 6.1% | 6.1% | 3.3% | 10.9% |
| Profit before tax | 2 | 2 | 2 | 6 | 2 | 2 | 1 | 6 |
| Tax rate | 7.6% | 8.2% | 22.0% | 21.9% | 22.0% | 24.1% | 20.8% | 19.9% |
| Net profit | 2 | 2 | 2 | 5 | 2 | 2 | 1 | 5 |
| EPS ($ per share) | 0.60 | — | 0.44 | 1.26 | 0.50 | — | 0.26 | 1.32 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 48 | 52 | 58 | 70 | 71 | 87 | 94 | 102 |
| Total liabilities | 57 | 55 | 67 | 67 | 85 | 51 | 55 | 53 |
| Fixed assets | 15 | 14 | 20 | 24 | 26 | 28 | 32 | 39 |
| Total assets | 109 | 111 | 130 | 144 | 164 | 149 | 162 | 171 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4 | 15 | 6 | 5 | 3 | 29 | 12 | 18 |
| Cash from investing | -3 | -2 | -14 | -6 | -14 | 7 | -13 | -12 |
| Cash from financing | -6 | -11 | 5 | 2 | 14 | -38 | 2 | -9 |
| Net cash flow | -5 | 2 | -3 | 1 | 3 | -2 | 1 | -3 |
| Capital expenditure | -3 | -2 | -3 | -6 | -4 | -5 | -7 | -11 |
| Free cash flow | 2 | 13 | 3 | -1 | -1 | 24 | 5 | 8 |
41 filings between Feb 27, 2026 and Oct 9, 2026.
Purchases
None
No insider bought shares.
Sales
$1.73M
13 sales by 4 insiders
Also filed: 3 dispositions to the issuer, 2 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| OLSCHAN BRIAN S | — | $1.27M | Aug 18, 2026 |
| BARKER BRIAN | — | $231.2K | Aug 13, 2026 |
| Davidson Rex Lynn | — | $208.1K | Aug 10, 2026 |
| HOLDEN RICHMOND Y JR | — | $21.1K | Oct 9, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | HOLDEN RICHMOND Y JR Director | Sale | 341 | $21.1K |
| Aug 18, 2026 | OLSCHAN BRIAN S President and COO | Sale | 4,000 | $245.4K |
| Aug 18, 2026 | OLSCHAN BRIAN S President and COO | Sale | 3,308 | $203.9K |
| Aug 13, 2026 | OLSCHAN BRIAN S President and COO | Tax withheld | 12,692 | $771.3K |
| Aug 13, 2026 | BARKER BRIAN Director | Sale | 3,821 | $231.2K |
| Aug 13, 2026 | OLSCHAN BRIAN S President and COO | Option exercise | 20,000 | $389.6K |
| Aug 12, 2026 | OLSCHAN BRIAN S President and COO | Sale | 339 | $19.8K |
| Aug 11, 2026 | BARKER BRIAN Director | Option exercise | 4,000 | $84.8K |
| Aug 11, 2026 | BARKER BRIAN Director | Tax withheld | 1,479 | $84.8K |
| Aug 11, 2026 | OLSCHAN BRIAN S President and COO | Sale | 159 | $9.2K |
| Aug 10, 2026 | OLSCHAN BRIAN S President and COO | Sale | 5,304 | $302.7K |
| Aug 10, 2026 | Davidson Rex Lynn Director | Sale | 3,684 | $208.1K |
| Aug 7, 2026 | OLSCHAN BRIAN S President and COO | Sale | 125 | $7.0K |
| Aug 5, 2026 | OLSCHAN BRIAN S President and COO | Sale | 4,000 | $222.0K |
| Aug 5, 2026 | Davidson Rex Lynn Director | Option exercise | 5,000 | $141.0K |
| Aug 5, 2026 | Davidson Rex Lynn Director | Tax withheld | 2,544 | $141.0K |
| Aug 4, 2026 | OLSCHAN BRIAN S President and COO | Sale | 981 | $55.7K |
| Aug 3, 2026 | OLSCHAN BRIAN S President and COO | Sale | 1 | $58 |
| Jul 29, 2026 | JOHNSEN WALTER C Chairman and CEO | Tax withheld | 20,361 | $1.22M |
| Jul 29, 2026 | DRISCOLL PAUL G Chief Financial Officer | Option exercise | 15,000 | $373.8K |
| Jul 29, 2026 | DRISCOLL PAUL G Chief Financial Officer | Tax withheld | 10,300 | $617.0K |
| Jul 29, 2026 | JOHNSEN WALTER C Chairman and CEO | Option exercise | 30,000 | $719.7K |
| Jul 24, 2026 | OLSCHAN BRIAN S President and COO | Option exercise | 35,000 | $793.1K |
| Jul 24, 2026 | OLSCHAN BRIAN S President and COO | Tax withheld | 24,091 | $1.30M |
| Jul 24, 2026 | HOLDEN RICHMOND Y JR Director | Tax withheld | 606 | $31.8K |
| Jul 24, 2026 | HOLDEN RICHMOND Y JR Director | Tax withheld | 788 | $41.3K |
| Jul 24, 2026 | HOLDEN RICHMOND Y JR Director | Option exercise | 1,900 | $41.3K |
| Jul 24, 2026 | HOLDEN RICHMOND Y JR Director | Option exercise | 1,500 | $31.8K |
| May 28, 2026 | OLSCHAN BRIAN S President and COO | Sale | 4,833 | $203.0K |
| May 27, 2026 | JOHNSEN WALTER C Chairman and CEO | Gift | 5,834 | $246.4K |
| May 21, 2026 | OLSCHAN BRIAN S President and COO | Option exercise | 20,000 | $498.4K |
| May 21, 2026 | OLSCHAN BRIAN S President and COO | Tax withheld | 15,204 | $657.0K |
| May 13, 2026 | JOHNSEN WALTER C Chairman and CEO | Option exercise | 30,000 | $719.7K |
| May 13, 2026 | JOHNSEN WALTER C Chairman and CEO | Tax withheld | 24,166 | $979.4K |
| Mar 3, 2026 | MURPHY SUSAN H Director | Gift | 1,200 | $52.9K |
| Feb 27, 2026 | OLSCHAN BRIAN S President and COO | Disposition to issuer | 15,000 | $688.2K |
| Feb 27, 2026 | DRISCOLL PAUL G Chief Financial Officer | Option exercise | 15,000 | $322.4K |
| Feb 27, 2026 | OLSCHAN BRIAN S President and COO | Option exercise | 15,000 | $373.8K |
| Feb 27, 2026 | JOHNSEN WALTER C Chairman and CEO | Option exercise | 30,000 | $644.7K |
| Feb 27, 2026 | JOHNSEN WALTER C Chairman and CEO | Disposition to issuer | 30,000 | $1.38M |
| Feb 27, 2026 | DRISCOLL PAUL G Chief Financial Officer | Disposition to issuer | 15,000 | $688.2K |
| Sep 5, 2025 | HOLDEN RICHMOND Y JR Director | Disposition to issuer | 2,500 | $110.9K |
| Sep 5, 2025 | HOLDEN RICHMOND Y JR Director | Option exercise | 2,500 | $53.0K |
| Aug 13, 2025 | HOLDEN RICHMOND Y JR Director | Disposition to issuer | 2,500 | $111.5K |
| Aug 13, 2025 | HOLDEN RICHMOND Y JR Director | Option exercise | 2,500 | $56.6K |
| Jul 29, 2025 | MURPHY SUSAN H Director | Gift | 120 | $5.1K |
| Jun 3, 2025 | OLSCHAN BRIAN S President and COO | Sale | 1,001 | $40.1K |
| Jun 2, 2025 | OLSCHAN BRIAN S President and COO | Sale | 809 | $32.3K |
| May 20, 2025 | OLSCHAN BRIAN S President and COO | Sale | 306 | $12.2K |
| May 19, 2025 | OLSCHAN BRIAN S President and COO | Sale | 690 | $27.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow ACME UNITED CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading